These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34113784)

  • 41. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Lee EG; Chen S; Leong L; Tulloch J; Yu CE
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34204109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chromosomal DNA damage in APOE ɛ4 carriers and noncarriers does not appear to be different.
    Chua A; Thomas P; Clifton P; Fenech M
    Environ Mol Mutagen; 2015 Oct; 56(8):694-708. PubMed ID: 25820038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
    Bagnoli S; Piaceri I; Tedde A; Bessi V; Bracco L; Sorbi S; Nacmias B
    Neurol Sci; 2013 Jun; 34(6):995-8. PubMed ID: 23546992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?
    Ba M; Kong M; Li X; Ng KP; Rosa-Neto P; Gauthier S
    Transl Neurodegener; 2016; 5():20. PubMed ID: 27891223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Cheng YC; Huang YC; Liu HC
    Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of interleukin 6 by a polymorphic CpG within the frontal cortex in Alzheimer's disease.
    Sawkulycz X; Bradburn S; Robinson A; Payton A; Pendleton N; Murgatroyd C
    Neurobiol Aging; 2020 Aug; 92():75-81. PubMed ID: 32408055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biothiols and oxidative stress markers and polymorphisms of
    Prendecki M; Florczak-Wyspianska J; Kowalska M; Ilkowski J; Grzelak T; Bialas K; Wiszniewska M; Kozubski W; Dorszewska J
    Oncotarget; 2018 Oct; 9(81):35207-35225. PubMed ID: 30443289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APOE DNA methylation is altered in Lewy body dementia.
    Tulloch J; Leong L; Chen S; Keene CD; Millard SP; Shutes-David A; Lopez OL; Kofler J; Kaye JA; Woltjer R; Nelson PT; Neltner JH; Jicha GA; Galasko D; Masliah E; Leverenz JB; Yu CE; Tsuang D
    Alzheimers Dement; 2018 Jul; 14(7):889-894. PubMed ID: 29544979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic risk for Alzheimer's disease influences neuropathology via multiple biological pathways.
    Hannon E; Shireby GL; Brookes K; Attems J; Sims R; Cairns NJ; Love S; Thomas AJ; Morgan K; Francis PT; Mill J
    Brain Commun; 2020; 2(2):fcaa167. PubMed ID: 33376986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
    Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
    Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal analysis of
    Fokuoh E; Xiao D; Fang W; Liu Y; Lu Y; Wang K
    J Genet; 2021; 100():. PubMed ID: 34470924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
    Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J
    Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E.
    Helisalmi S; Valve R; Karvonen MK; Hiltunen M; Pirskanen M; Mannermaa A; Koulu M; Pesonen U; Uusitupa M; Soininen H
    Neurosci Lett; 2000 Jun; 287(1):25-8. PubMed ID: 10841982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
    Konishi K; Joober R; Poirier J; MacDonald K; Chakravarty M; Patel R; Breitner J; Bohbot VD
    J Alzheimers Dis; 2018; 61(4):1493-1507. PubMed ID: 29278888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    Chen XR; Shao Y; Sadowski MJ;
    J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
    Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.
    Bangen KJ; Himali JJ; Beiser AS; Nation DA; Libon DJ; Fox CS; Seshadri S; Wolf PA; McKee AC; Au R; Delano-Wood L
    J Alzheimers Dis; 2016 Jul; 53(4):1553-62. PubMed ID: 27392855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.